Herbas VPB

Print
EN | LT
LT - DR5 agonisto ir anti-PD-1 antagonisto derinys ir naudojimo būdai
EN - COMBINATION OF DR5 AGONIST AND ANTI-PD-1 ANTAGONIST AND METHODS OF USE

Legal status

Patent lapsed (non-payment of fees)

Claims | Licences
Bibliographic data
Indications of the International Patent Classification (IPC)
(51) INT.CL. C07K 16/28 (2006.01)
European patent
(11) Number of the document 2970473
(13) Kind of document T
(96) European patent application number 14717294.4
Date of filing the European patent application 2014-03-12
(97) Date of publication of the European application 2016-01-20
(45) Date of publication and mention of the grant of the patent 2017-08-16
(46) Date of publication of the claims translation 2017-10-25
PCT application
(86) Number PCT/US2014/024208
Date 2014-03-12
PCT application publication
(87) Number WO 2014/159562
Date 2014-10-02
Priority applications
(30) Number Date Country code
201361783184 P 2013-03-14 US
Inventors
(72)
BARNHART, Bryan, US
JURE-KUNKEL, Maria, N., US
Grantee
(73) Bristol-Myers Squibb Company, Route 206 and Province Line Road, Princeton, NJ 08543, US
Attorney or representative
(74) Jurga PETNIŪNAITĖ, AAA Law, A. Goštauto g. 40B, Verslo centras "Dvyniai", LT-03163 Vilnius, LT
Title
(54) DR5 agonisto ir anti-PD-1 antagonisto derinys ir naudojimo būdai
  COMBINATION OF DR5 AGONIST AND ANTI-PD-1 ANTAGONIST AND METHODS OF USE
Last renewal fee
Payment date Validity (years) Amount
2019-02-21 6 139.00 EUR
Legal status
Patent lapsed (non-payment of fees)
Invalidation date 2020-03-12
Last update date 2021-11-25